Vocabria Tablet, Film Coated
Product Images NDC 49702-248

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Vocabria (NDC 49702-248). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Viiv Healthcare Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Vocabria Spl Graphic 1)

Chemical structure of cabotegravir sodium, the active ingredient in Vocabria. The structure includes a fluorinated phenyl ring, a sodium carboxylate group, and multiple heterocyclic components.*

FDA Label Image

Vocabria Tablet 30 mg 30 Count Label (Vocabria Spl Graphic 2)

Label for Vocabria (cabotegravir) 30 mg film-coated tablets by ViiV Healthcare Company. The label states the product contains 30 tablets, each with 30 mg cabotegravir. It includes warnings about child resistance and to keep out of reach of children, storage instructions below 30°C, and a pharmacist alert regarding medicines not to be taken with Vocabria. Additional manufacturer information by GlaxoSmithKline and a QR code are visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.